2023 | Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
| JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION |
2023 | Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study | HEPATOLOGY |
2023 | Association of Alcohol Consumption With Liver Cancer and All-Cause Mortality in Chronic Hepatitis B Patients Without Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
2023 | Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2023 | Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
| LIVER CANCER |
2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | How to deliver palliative care for patients with management in decompensated cirrhosis
| HEPATOBILIARY SURGERY AND NUTRITION |
2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2023 | Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2023 | UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2023 | Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis
| CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2023 | Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis | HEPATOLOGY |
2023 | Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study
| CLINICAL AND MOLECULAR HEPATOLOGY |
2023 | Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma | EUROPEAN JOURNAL OF CLINICAL INVESTIGATION |
2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
2023 | Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
| CANCER MEDICINE |
2023 | Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2023 | Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
2023 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Dise | GUT AND LIVER |
2022 | New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2022 | Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study | HEPATOLOGY RESEARCH |
2022 | Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD | JOURNAL OF HEPATOLOGY |
2022 | How to Optimize the Care Cascade of Hepatitis C Virus Infection
| GUT AND LIVER |
2022 | Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2022 | Response to Liao et al. | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2022 | Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
| CLINICAL AND MOLECULAR HEPATOLOGY |
2022 | Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants | GASTROENTEROLOGY |
2022 | Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
| CANCERS |
2022 | Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
| Journal of Liver Cancer(대한간암학회지) |
2022 | The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials | OBESITY REVIEWS |
2022 | Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis
| INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES |
2022 | Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study
| HEPATOLOGY COMMUNICATIONS |
2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
2022 | Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2022 | Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk | LIVER INTERNATIONAL |
2022 | Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
| GASTROENTEROLOGY REPORT |
2022 | Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2022 | Evidence of nonsurgical treatment for polycystic liver disease
| THERAPEUTIC ADVANCES IN CHRONIC DISEASE |
2022 | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B | DIGESTIVE DISEASES AND SCIENCES |
2022 | Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis
| JAMA NETWORK OPEN |
2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
2022 | Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
2022 | Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
| FRONTIERS IN MEDICINE |